Histiocytosis and Storage Diseases

  • Samuel P. Hammar
  • Timothy C. Allen


Histiocytoses of the lung include a variety of diseases for which the unifying characteristic is the accumulation of histiocytic cells within lung parenchyma or air spaces. The diseases include macrophage and dendritic cell disorders as well as storage diseases that result in the accumulation of histiocytic cells in the lung. Pulmonary Langerhans’ cell histiocytosis is the most common of these disorders. The histologic, radiologic, immunohistochemical, and, where relevant, ultrastructural characteristics of these diseases are compared in Table 16.1 and discussed in the various sections of this chapter.


Alveolar Macrophage Idiopathic Pulmonary Fibrosis Storage Disease Eosinophilic Granuloma Sinus Histiocytosis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Langerhans P. Uber die Nerven der menschlichen Haut. Virchows Arch A Pathol Pathol Anat 1868;44:325–337.Google Scholar
  2. 2.
    Lampert F. Langerhans cell histiocytosis: historical perspectives. Hematol Oncol Clin North Am 1998;12:213–219.PubMedGoogle Scholar
  3. 3.
    Birbeck MS, Breathnach AD, Everall JD. An electron microscope study of basal melanocytes and high-level clear cells (Langerhans cells) in vitiligo. J Invest Dermatol 1961;37:51–64.Google Scholar
  4. 4.
    Basset F, Turiaf J. Identification par la microscopic electronique de particles de nature probablement virale dans les lesions granulomateuses d’une histiocytose X pulmonaire. C R Seances Acad Sci (Paris) 1965;261:3701–3703.Google Scholar
  5. 5.
    Katz SI, Tamaki K, Sachs DH. Epidermal Langerhans cells are derived from cells originating in bone marrow. Nature (London) 1979;282:324–326.PubMedGoogle Scholar
  6. 6.
    Wood GS, Morhenn VB, Butcher EC, Kosek J. Langerhans cells react with panleukocyte monoclonal antibody. Ultrastructural documentation using a live cell suspension immunoperoxidase technique. J Invest Dermatol 1984;82:322–325.PubMedGoogle Scholar
  7. 7.
    Stingl G, Wolff-Schreiner EC, Pichler WJ, Gschnait F, Knapp W. Epidermal Langerhans cells bear Fc and C3 receptors. Nature (London) 1977;268:245–246.PubMedGoogle Scholar
  8. 8.
    Rowden G, Lewis MC, Sullivan AK. Ia antigen expression on human Langerhans cells. Nature (London) 1977;268:247–248.PubMedGoogle Scholar
  9. 9.
    Murphy GF, Bhan AK, Sato S, Harrist JJ, Mihm MC. Characterization of Langerhans cells by the use of monoclonal antibodies. Lab Invest 1981;45:465–468.PubMedGoogle Scholar
  10. 10.
    Favara BE, McCarthy RC, Mierau GW. Histiocytosis X. Hum Pathol 1983;14:663–676.PubMedGoogle Scholar
  11. 11.
    Beckstead JH, Wood GS, Turner RR. Histiocytosis X cells and Langerhans cells: enzyme histochemical and immunologic similarities. Hum Pathol 1984;15:826–833.PubMedGoogle Scholar
  12. 12.
    Takahashi K, Isobe T, Ohtsuki Y, Sonobe H, et al. Immunohistochemical localization and distribution of S-100 protein in human lymphoreticular system. Am J Pathol 1984;116:497–503.PubMedGoogle Scholar
  13. 13.
    Wood GS, Turner RR, Shiurba RA, Eng L, Warnke RA. Human dendritic cells and macrophages: in situ immunophenotypic definition of subsets that exhibit specific morphologic and microenvironmental characteristics. Am J Pathol 1985;119:73–82.PubMedGoogle Scholar
  14. 14.
    Franklin WA, Mason DY, Pulford K, et al. Immunohistologic analysis of human mononuclear phagocytes and dendritic cells by using monoclonal antibodies. Lab Invest 1986;54:322–335.PubMedGoogle Scholar
  15. 15.
    Rochester CL, Goodell EM, Stoltenborg JK, Bowers WE. Dendritic cells from rat lung are potent accessory cells. Am Rev Respir Dis 1988;138:121–128.PubMedGoogle Scholar
  16. 16.
    Toews GB. Pulmonary dendritic cells: sentinels of lung-associated lymphoid tissues. Am J Respir Cell Mol Biol 1991;4:204–205.PubMedGoogle Scholar
  17. 17.
    Murphy GF, Messadi D, Fonferko I, Hancock WW. Phenotypic transformation of macrophages to Langerhans cells in the skin. Am J Pathol 1986;123:401–406.PubMedGoogle Scholar
  18. 18.
    Komp DM. Langerhans cell histiocytosis. N Engl J Med 1987;316:747–748.PubMedGoogle Scholar
  19. 19.
    Hammar S. Langerhans cells. Pathol Ann 1988;23 (pt 2):293–328.Google Scholar
  20. 20.
    Hammar S, Bockus D, Remington F, Bartha M. The widespread distribution of Langerhans’ cells in pathologic conditions: an ultrastructural and immunohistochemical study. Hum Pathol 1986;17:894–905.PubMedGoogle Scholar
  21. 21.
    Farber S. The nature of “solitary or eosinophilic granuloma” of bone. Am J Pathol 1941;17:625.Google Scholar
  22. 22.
    Lichtenstein L. Histiocytosis X. Integration of eosinophilic granuloma of bone. “Letterer-Siwe disease” and “Hand-Schuller-Christian disease” as related manifestations of a single nosologic entity. Arch Pathol Lab Med 1953;56:84–102.Google Scholar
  23. 23.
    Lieberman P, Jones C, Dargeon H, Begg CF. A reappraisal of eosinophilic granuloma of bone, Hand-Schuller-Christian syndrome and Letterer-Siwe syndrome. Medicine (Baltimore) 1969;48:375–400.PubMedGoogle Scholar
  24. 24.
    Vogel JM, Vogel P. Idiopathic histiocytosis: a discussion of eosinophilic granuloma, the Hand-Schuller-Christian syndrome and the Letterer-Siwe syndrome. Semin Hematol 1972;9:349–369.PubMedGoogle Scholar
  25. 25.
    Beverly PCL, Egeler RM, Arceci RJ, Pritchard J. The Nikolas Symposia and histiocytosis. Nature Reviews/ Cancer 2005;5:488–494.Google Scholar
  26. 26.
    Vermaelen K, Pauwels R. Pulmonary dendritic cells. Am J Respir Crit Care Med 2005;172:530–551.PubMedGoogle Scholar
  27. 27.
    Writing Group of the Histiocyte Society. Chu T, D’Angio GJ, Favara BE, et al. Histiocytosis syndromes in children. Lancet 1987;1:208–209.Google Scholar
  28. 28.
    Schmitz L, Favara BE. Nosology and pathology of Lang-erhans cell histiocytosis. Hematol Oncol Clin North Am 1998;12:221–246.PubMedGoogle Scholar
  29. 29.
    Lewis JG. Eosinophilic granuloma and its variants with special reference to lung involvement. A report of 12 patients. Q J Med 1964;33:337–359.PubMedGoogle Scholar
  30. 30.
    Parkinson T. Eosinophilic xanthomatous granuloma with honeycomb lungs. Br Med J 1949;1:1029–1030.PubMedGoogle Scholar
  31. 31.
    Oswald N, Parkinson T. Honeycomb lungs. Q J Med 1949;18:1–20.PubMedGoogle Scholar
  32. 32.
    Cunningham GJ, Parkinson T. Diffuse cystic lungs of granulomatous origin. A histological study of six cases. Thorax 1950;5:43–58.Google Scholar
  33. 33.
    Farinacci CJ, Jeffrey HC, Lackey RW. Eosinophilic granuloma of the lung. Report of two cases. US Armed Forces Med J 1951;2:1085–1093.Google Scholar
  34. 34.
    Mazitello WF. Eosinophilic granuloma of the lung. N Engl J Med 1954;250:804–809.Google Scholar
  35. 35.
    Auld D. Pathology of eosinophilic granuloma. AM A Arch Pathol 1957;63:113–131.Google Scholar
  36. 36.
    Basset F, Corrin B, Spencer H, et al. Pulmonary histiocytosis X. Am Rev Respir Dis 1978;118:811–820.PubMedGoogle Scholar
  37. 37.
    Friedman PJ, Liebow AA, Sokoloff J. Eosinophilic granuloma of lung: clinical aspects of primary pulmonary histiocytosis in the adult. Medicine (Baltimore) 1981;60:385–396.PubMedGoogle Scholar
  38. 38.
    Colby TV, Lombard C. Histiocytosis X in the lung. Hum Pathol 1983;14:847–856.PubMedGoogle Scholar
  39. 39.
    Egeler RM, D’Angio GJ. Clinical aspects of Langerhans cell histiocytosis. Hematol Oncol Clin North Am 1998;12:247–258.PubMedGoogle Scholar
  40. 40.
    Vassallo R, Ryu JH, Colby TV, et al. Pulmonary Langer-hans’-cell histiocytosis. N Engl J Med 2000;342:1969–1978.PubMedGoogle Scholar
  41. 41.
    Tazi A, Soler P, Hance AJ. Adult pulmonary Langerhans’ cell histiocytosis. Thorax 2000;55:405–416.PubMedGoogle Scholar
  42. 42.
    Sundar KM, Gosselin MV, Chung HL, Cahill BC. Pulmonary Langerhans’ cell histiocytosis: emerging concepts in pathobiology, radiology and clinical evolution of disease. Chest 2003;123:1673–1683.PubMedGoogle Scholar
  43. 43.
    Vassallo R, Ryu JH. Pulmonary Langerhans’ cell histiocytosis. Clin Chest Med 2004;25:561–571.PubMedGoogle Scholar
  44. 44.
    Gaensler AE, Carrington CB. Open biopsy for chronic diffuse infiltrative lung disease: clinical, roentgenographic and physiological correlations in 502 patients. Ann Thorac Surg 1980;30:411–426.PubMedGoogle Scholar
  45. 45.
    Agostini C, Albera C, Bariffl F, et al. First report of the Italian register for diffuse infiltrative lung disorders (RIPID). Monaldi Arch Chest Dis 2001;56:364–368.PubMedGoogle Scholar
  46. 46.
    Travis WD, Borok Z, Roum JH, et al. Pulmonary Langerhans’ cell granulomatosis (histiocytosis X): a clinicopatho-logic study of 48 cases. Am J Surg Pathol 1993;17:971–986.PubMedGoogle Scholar
  47. 47.
    Schonfeld N, Frank W, Wenig S, et al. Clinical and radiologic features, lung function and therapeutic results in pulmonary histiocytosis X. Respiration (Herrlisheim) 1993;60:38–44.PubMedGoogle Scholar
  48. 48.
    Zeid NA, Muller HK. Tobacco smoked induced lung granulomas and tumors: association with pulmonary Langerhans cells. Pathol 1995;27:247–254.Google Scholar
  49. 49.
    Casolaro MA, Bernaudin JF, Saltini C, et al. Accumulation of Langerhans’ cells on the epithelial surface of the lower respiratory tract in normal subjects in association with cigarette smoking. Am Rev Respir Dis 1998;137:406–411.Google Scholar
  50. 50.
    Etienne B, Bertocchi M, Gamondes J, et al. Relapsing pulmonary Langerhans cell histiocytosis after lung transplantation. Am J Respir Crit Care Med 1998;157:288–291.PubMedGoogle Scholar
  51. 51.
    Habib SB, Congleton J, Cari D, et al. Recurrence of recipient Langerhans’ cell histiocytosis following bilateral lung transplantation. Thorax 1998;53:323–325.PubMedGoogle Scholar
  52. 52.
    Hirsch MS, Hong CK. Familial pulmonary histiocytosis-X. Am Rev Respir Dis 1973;107:831–835.PubMedGoogle Scholar
  53. 53.
    Villar TG, Avila R, Marques RA. Eosinophilic granuloma of the lung and the extrinsic pulmonary granulomatoses. Ann NY Acad Sci 1976;278:612–617.PubMedGoogle Scholar
  54. 54.
    Girard P, Bouzakoura C. Eosinophilic granuloma of the lung with sawdust and horse serum hypersensitivity. Clin Allergy 1974;4:71–78.PubMedGoogle Scholar
  55. 55.
    Thompson JR, Langer S. Eosinophilic granuloma of the lungs. Dis Chest 1964;46:553–561.PubMedGoogle Scholar
  56. 56.
    King TE, Schwarz MI, Dreisin RE, Pratt DS, Theofilopoulos AN. Circulating immune complexes in pulmonary eosinophilic granuloma. Ann Intern Med 1979;91:397–399.PubMedGoogle Scholar
  57. 57.
    Dreisen RB, Schwarz MI, Theofilopoulous AN, Stanford RE. Circulating immune complexes in the idiopathic interstitial pneumonias. N Engl J Med 1978;298:353–357.Google Scholar
  58. 58.
    Haslam PM. Circulating immune complexes in patients with cryptogenic fibrosing alveolitis. Clin Exp Immunol 1979;37:381–390.PubMedGoogle Scholar
  59. 59.
    Ahnquist G, Holyoke JB. Congenital Letterer-Siwe disease (reticuloendotheliosis) in a term stillborn infant. J Pediatr 1960;57:897–904.PubMedGoogle Scholar
  60. 60.
    Claman HN, Suvatte V, Githens JH, Hathaway WE. Histiocytic reaction in dysgammaglobulinemia and congenital rubella. Pediatrics 1970;46:89–96.PubMedGoogle Scholar
  61. 61.
    van der Loo FM, van Muijen GNP, van Vloten WA, Beens W, Scheffer F, Meijer CJLM. C-type virus-like particles specifically localized in Langerhans cells and related cells of skin and lymph nodes of patients with mycosis fungoi-des and Sezary syndrome. Virchows Arch B Cell Pathol Incl Mol Pathol 1979;31:193–203.PubMedGoogle Scholar
  62. 62.
    Osband ME, Lipton JM, Lavin P, et al. Histiocytosis X: demonstration of abnormal immunity, T-cell histamine H2-receptor deficiency and successful treatment with thymic extract. N Engl J Med 1981;304:146–153.PubMedGoogle Scholar
  63. 63.
    Miller LG, Goldstein G, Murphy M, Ginns LC. Reversible alterations in immunoregulatory T cells in smoking: analysis by monoclonal antibodies and flow cytometry. Chest 1982;82:526–529.PubMedGoogle Scholar
  64. 63.
    Gerard JW, Heiner PC, Mink J, Meyers A, Dosman JA. Immunoglobulin levels in smokers and non-smokers. Ann Allergy 1980;44:261–262.Google Scholar
  65. 65.
    Ferson M, Edwards A, Lind A, Milton GW, Hersey P. Low natural killer-cell activity and immunoglobulin levels associated with smoking in human subjects. Int J Cancer 1979;23:603–609.PubMedGoogle Scholar
  66. 66.
    Cryer PE, Haymond MW, Santiago JV, Shah SD. Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events. N Engl J Med 1976;295:573–577.PubMedGoogle Scholar
  67. 67.
    Miller CL, Baker CC. Changes in lymphocyte activity after injury. J Clin Invest 1977;63:202–210.Google Scholar
  68. 68.
    Wang BS, Heacock EH, Wu AV, Mannick JA. Generation of suppressor cells in mice after surgical trauma. J Clin Invest 1980;66:200–209.PubMedGoogle Scholar
  69. 69.
    Hoogsteden HC, van Hal PThW, Wijkhuijs JM, Hop W, Verkaik APK, Hilvering C. Expression of the CD11/CD18 cell surface adhesion glycoprotein family on alveolar macrophages in smokers and nonsmokers. Chest 1991;100:1567–1571.PubMedGoogle Scholar
  70. 70.
    Senior RM, Kuhn C III. The pathogenesis of emphysema. In: Fishman AP, ed. Pulmonary diseases and disorders, vol 2, 2nd ed. New York: McGraw-Hill, 1988:1209–1219.Google Scholar
  71. 71.
    Kasama T, Kobayashi K, Fukushima T, et al. Production of interleukin 1-like factor from human peripheral blood monocytes and polymorphonuclear leukocytes by superoxide anion: the role of interleukin 1 and reactive oxygen species in inflamed sites. Clin Immunol Immunopathol 1989;53:439–448.PubMedGoogle Scholar
  72. 72.
    Renoux M, Lemarie E, Renoux G. Interleukin-1 secretion by lipopolysaccharide-stimulated alveolar macrophages. Respiration 1989;55:158–168.PubMedGoogle Scholar
  73. 73.
    Rothlein R, Czajkowski M, O’Neill MM, Marlin SD, Mainolfi E, Merluzzi VJ. Induction of intercellular adhesion molecule 1 on primary and continuous cell lines by pro-inflammatory cytokines: regulation by pharmacologic agents and neutralizing antibodies. J Immunol 1988;141:1665–1669.PubMedGoogle Scholar
  74. 74.
    Barbers RG, Evans MJ, Gong H Jr, Tashkin DP. Enhanced alveolar monocytic phagocyte (macrophage) proliferation in tobacco and marijuana smokers. Am Rev Respir Dis 1991;143:1092–1095.PubMedGoogle Scholar
  75. 75.
    Coggle JE, Tarling JD. The proliferation kinetics of pulmonary alveolar macrophages. J Leukocyte Biol 1984;35:317–327.PubMedGoogle Scholar
  76. 76.
    Bitterman PB, Saltzman LE, Adelberg S, Ferrans VJ, Crystal RG Alveolar macrophage replication. One mechanism for the expansion of the mononuclear phagocyte population in the chronically inflamed lung. J Clin Invest 1984;74:460–469.PubMedGoogle Scholar
  77. 77.
    Evans MJ, Sherman MP, Campbell LA, Shami SG. Proliferation of pulmonary alveolar macrophages during postnatal development of rabbit lungs. Am Rev Respir Dis 1987;136:384–387.PubMedGoogle Scholar
  78. 78.
    Evans MJ, Shami SG, Martinez LA. Enhanced proliferation of pulmonary macrophages after carbon instillation in mice depleted of blood monocytes by strontium-89. Lab Invest 1986;54:154–159.PubMedGoogle Scholar
  79. 79.
    Blusse Van OudAlblas A, VanFurth R. Origin, kinetics and characteristics of pulmonary macrophages in the normal steady state. J Exp Med 1979;149:1504–1518.Google Scholar
  80. 80.
    Shellito J, Esparza C, Armstrong C. Maintenance of the normal rat alveolar macrophage cell population. The roles of monocyte influx and alveolar macrophage proliferation in situ. Am Rev Respir Dis 1987;135:78–82.PubMedGoogle Scholar
  81. 81.
    Golde DW, Byers LA, Finley TN. Proliferative capacity of human alveolar macrophages. Nature (London) 1974;247:373–375.PubMedGoogle Scholar
  82. 82.
    Sawyer RT. The significance of local resident pulmonary alveolar macrophages in monocytopenic mice. J Leukocyte Biol 1986;39:77–87.PubMedGoogle Scholar
  83. 83.
    Sherman MP, Evans MJ, Campbell LA. Prevention of pulmonary alveolar macrophage proliferation in newborn rabbits by hyperoxia. J Pediatr 1988;112:782–786.PubMedGoogle Scholar
  84. 84.
    Barbers RG, Oishi J, Gong H Jr, Tashkin DP, Wallace JM, Baker SS. Chemotaxis of peripheral blood and lung leukocytes obtained from tobacco and marijuana smokers. J Psychoact Drugs 1988;20:15–20.Google Scholar
  85. 85.
    Tashkin DP, Coulson AH, Clark VA, et al. Respiratory symptoms and lung function in habitual heavy smokers of marijuana alone, smokers of marijuana and tobacco, smokers of tobacco alone, and nonsmokers. Am Rev Respir Dis 1988;138:74–80.Google Scholar
  86. 86.
    Hunninghake GW, Crystal RG. Cigarette smoking and lung destruction. Am Rev Respir Dis 1983;128:873–878.Google Scholar
  87. 87.
    Aguayo SM, Kane MA, King TE Jr, Schwarz MI, Graver L, Miller YE. Increased levels of bombesin-like peptides in the lower respiratory tract of asymptomatic cigarette smokers. J Clin Invest 1989;84:1105–1113.PubMedGoogle Scholar
  88. 88.
    Aguayo SM, King TE Jr, Waldron JA, Sherritt KM, Kane MA, Miller YE. Increased pulmonary neuroendocrine cells with bombesin-like immunoreactivity in adult patients with eosinophilic granuloma. J Clin Invest 1990;86:838–844.PubMedGoogle Scholar
  89. 89.
    Barth J, Kreipe H, Radzun HJ, et al. Increased expression of growth factor genes for macrophages and fibroblasts in bronchoalveolar lavage cells of a patient with pulmonary histiocytosis X. Thorax 1991;46:835–838.PubMedGoogle Scholar
  90. 90.
    Brabencova F, Tazi A, Lorenzato M, et al. Langerhans cells in Langerhans’ cell granulomatosis are not actively proliferating cells. Am J Pathol 1998;152:1143–1149.PubMedGoogle Scholar
  91. 91.
    Yu RC, Cho C, Buluwela L, Chu AC. Clonal proliferation of Lahgerhans cells in Langerhans cell histiocytosis. Lancet 1994;343:767–768.PubMedGoogle Scholar
  92. 92.
    William CL, Busque L, Griffith BB, et al. Langerhans cell histiocytosis (histiocytosis X)—a clonal proliferative disorder. N Engl J Med 1994;331:154–160.Google Scholar
  93. 93.
    William CL, McClain KL. An update on clonality, cytokines and viral etiology in Langerhans cell histiocytosis. Hematol Oncol Clin North Am 1998;12:407–416.Google Scholar
  94. 94.
    Yousem SA, Colby TV, Chen YY, et al. Pulmonary Langerhans’ cell histiocytosis: molecular analysis of clonality. Am J Surg Pathol 2001;25:630–636.PubMedGoogle Scholar
  95. 95.
    Dacic S, Trusky C, Bakker A, et al. Genotypic analysis of pulmonary Langerhans’ cell histiocytosis. Hum Pathol 2003;34:1345–1349.PubMedGoogle Scholar
  96. 96.
    Egeler RM, Favara BE, van Meurs M, et al. Differential in situ cytokine profiles of Langerhans-like cells and T cells in Langerhans cell histiocytosis: abundant expression of cytokines relevant to disease and treatment. Blood 1999;94:4195–4201.PubMedGoogle Scholar
  97. 97.
    Tazi A, Moreau J, Bergeron A, et al. Evidence that Langerhans cells in adult pulmonary Langerhans cell histocyto-sis are mature dendritic cells: importance of the cytokine microenvironment. J Immunol 1999;163:3511–3515.PubMedGoogle Scholar
  98. 98.
    Geissmann F, Lepelletier Y, Fraitag S, et al. Differentiation of Langerhans cells in Langerhans cell histiocytosis. Blood 2001;97:1241–1248.PubMedGoogle Scholar
  99. 99.
    Annels NE, daCosta CET, Prins FA, et al. Aberrant che-mokine receptor expression and chemokine production of Langerhans cell underlies the pathogenesis of Langerhans cell histiocytosis. J Exp Med 2003;197:1385–1390.PubMedGoogle Scholar
  100. 100.
    Mendez JL, Nadrous HF, Vassallo K, et al. Pneumothorax in pulmonary Langerhans cell histiocytosis. Chest 2004;125:1028–1032.PubMedGoogle Scholar
  101. 101.
    Nakhla H, Jumbelic MI. Sudden death of a patient with pulmonary Langerhans’ cell histiocytosis. Arch Pathol Lab Med 2005;129:798–799.PubMedGoogle Scholar
  102. 102.
    Aftimos S, Nassar V, Najjar S. Primary pulmonary histiocytosis in an infant. Am J Dis Child 1974;128:851–852.PubMedGoogle Scholar
  103. 103.
    Chatkin JM, Bastos JC, Stein TA, Garger AM. Sole pulmonary involvement by Langerhans cell histiocytosis in a child. Eur Respir J 1993;6:1226–1228.PubMedGoogle Scholar
  104. 104.
    Guardia J, Pedreira J, Esteban R, Vargas V, Allende E. Early pleural effusion in histiocytosis X. Arch Intern Med 1979;139:934–936.PubMedGoogle Scholar
  105. 105.
    Masson RG, Tedeschi LG. Pulmonary eosinophilic granuloma with hilar adenopathy simulating sarcoidosis. Chest 1978;73:682–683.PubMedGoogle Scholar
  106. 106.
    Brambilla E, Fontaine E, Pison CM, Coulomb M, Paramelle B, Brambilla C. Pulmonary histiocytosis X with mediastinal lymph node involvement. Am Rev Respir Dis 1990;142:1216–1218.PubMedGoogle Scholar
  107. 107.
    Pomeranz SJ, Proto AV. Histiocytosis X. Unusual-confusing features of eosinophilic granuloma. Chest 1986;89:88–92.PubMedGoogle Scholar
  108. 108.
    Fichtenbaum CJ, Kleinman GM, Haddad RG. Eosinophilic granuloma of the lung presenting as a solitary pulmonary nodule. Thorax 1990;45:905–906.PubMedGoogle Scholar
  109. 109.
    Khoor A, Myers JL, Tazelaar HD, Swensen SJ. Pulmonary Langerhans cell histiocytosis presenting as a solitary nodule. Mayo Clin Proc 2001;76:209–211.PubMedGoogle Scholar
  110. 110.
    Sajjad SM, Luna MA. Primary pulmonary histiocytosis X in two patients with Hodgkin’s disease. Thorax 1982;37;110–113.PubMedGoogle Scholar
  111. 111.
    Wyre HW, Henrichs WD. Systemic mastocytosis and pulmonary eosinophilic granuloma. JAMA 1978;239:856–857.PubMedGoogle Scholar
  112. 112.
    Shanley DJ, Lerud KS, Luetkehans TJ. Development of pulmonary histiocytosis X after chemotherapy for Hodgkin disease. AJR 1990;155:741–742.PubMedGoogle Scholar
  113. 113.
    Coli A, Bigotti G, Ferrone S. Histiocytosis X arising in Hodgkin’s disease: immunophenotypic characterization with a panel of monoclonal antibodies. Virchows Arch A Pathol Anat 1991;418:369–373.Google Scholar
  114. 114.
    Fartoukh M, Humbert M, Capron F, et al. Severe pulmonary hypertension in histiocytosis X. Am J Respir Crit Care Med 2000;161:216–223.PubMedGoogle Scholar
  115. 115.
    LaCronique J, Roth C, Battesti JP, Basset F, Chretien J. Chest radiological features of pulmonary histiocytosis X. A report based on 50 adult cases. Thorax 1982;37:104–109.PubMedGoogle Scholar
  116. 116.
    Moor ADA, Godwin JD, Muller NL, et al. Pulmonary histiocytosis X: comparison of radiographic findings. Radiology 1989;172:249–254.Google Scholar
  117. 117.
    Taylor DB, Joske D, Anderson J, Barry-Walsh C. Cavitating pulmonary nodules in histiocytosis X: high resolution CT demonstration. Aust Radiol 1990;34:253–255.Google Scholar
  118. 118.
    Lastoria S, Montella L, Catalano L, et al. Functional imaging of Langerhans cell histiocytosis by 111In-DTPA-D-Phe1−octreotide scintigraphy. Cancer 2002;94:633–640.PubMedGoogle Scholar
  119. 119.
    Bedrossian CWM, Kuhn C III, Luna MA, Conklin RH, Byrd RB, Kaplan PD. Desquamative interstitial pneumonia-like reaction accompanying pulmonary lesions. Chest 1977;72:166–169.PubMedGoogle Scholar
  120. 120.
    Fukuda Y, Basset F, Soler P, et al. Intraluminal fibrosis and elastic fiber degradation lead to lung remodeling in pulmonary Langerhans’ cell granulomatosis (histiocytosis X). Am J Pathol 1990;137:415–424.PubMedGoogle Scholar
  121. 121.
    Kambouchner M, Basset F, Marchal J, et al. Three-dimensional characterization of pathologic lesions in pulmonary Langerhans cell histiocytosis. Am J Respir Crit Care Med 2002;166:1483–1490.PubMedGoogle Scholar
  122. 122.
    Abbott GF, Rosado-de-Christenson ML, et al. From the archives of the AFIP: pulmonary Langerhans cell histiocytosis. RadioGraphics 2004;24:821–841.PubMedGoogle Scholar
  123. 123.
    Askin FB, McCann BG, Kuhn C III. Reactive eosinophilic pleuritic. A lesion to be distinguished from pulmonary eosinophilic granuloma. Arch Pathol Lab Med 1977;101:187–191.PubMedGoogle Scholar
  124. 124.
    McDonnell TJ, Crouch EC, Gonzalez JG. Reactive eosinophilic pleuritis: a sequelae of pneumothorax in pulmonary eosinophilic granuloma. Am J Clin Pathol 1989;91:107–109.PubMedGoogle Scholar
  125. 125.
    Hammar SP, Winterbauer RH, Bockus D, Remington F, Friedman S. Idiopathic fibrosing alveolitis: a review with emphasis on ultrastructural and immunohistochemical features. Ultrastruct Pathol 1985;9:345–372.PubMedGoogle Scholar
  126. 126.
    Hammar SP, Bolen JW, Bockus D, Remington F, Friedman S. Ultrastructural and immunohistochemical features of common lung tumors. An overview. Ultrastruct Pathol 1985;9:283–318.PubMedGoogle Scholar
  127. 127.
    Hammar SP, Bockus D, Remington F, et al. Langerhans cells and serum precipitating antibodies against fungal antigen in bronchiolo-alveolar cell carcinomas: possible association with eosinophilic granuloma. Ultrastruct Pathol 1980;1:19–37.PubMedGoogle Scholar
  128. 128.
    Lombard CM, Medeiros J, Colby TV. Pulmonary histiocytosis X and carcinoma. Arch Pathol Lab Med 1987;111:339–341.PubMedGoogle Scholar
  129. 129.
    Sadoun D, Vaylet F, Valeyre D, et al. Bronchogenic carcinoma in patients with pulmonary histiocytosis X. Chest 1992;101:1610–1613.PubMedGoogle Scholar
  130. 130.
    Tomashefski JF, Khiyami A, Kleinerman J. Neoplasms associated with pulmonary eosinophilic granuloma. Arch Pathol Lab Med 1991;115:499–506.PubMedGoogle Scholar
  131. 131.
    Egan AJM, Boardman LA, Tazelaar HD, et al. Erdheim-Chester disease: clinical, radiologic, and histopathologic findings in five patients with interstitial lung disease. Am J Surg Pathol 1999;23(1):17–26.PubMedGoogle Scholar
  132. 132.
    Rush WL, Andriko JAW, Galateau-Salle F, et al. Pulmonary pathology of Erdheim-Chester disease. Mod Pathol 2000;13(6):747–754.PubMedGoogle Scholar
  133. 133.
    Allen TC, Chevez-Barrios P, Shetlar DJ, et al. Pulmonary and ophthalmic involvement with Erdheim-Chester disease: a case report and review of the literature. Arch Pathol Lab Med 2004;128:1428–1431.PubMedGoogle Scholar
  134. 134.
    Rao NR, Chang C, Uysal N, et al. Fulminant multisystem non-Langerhans cell histiocytic proliferation with hemo-phagocytosis: a variant form of Erdheim-Chester disease. Arch Pathol Lab Med 2005;129:e39–e43.PubMedGoogle Scholar
  135. 135.
    Shah RN, Ozen O, Yeldandi A, et al. Follicular dendritic cell tumor presenting in the lung: a case report. Hum Pathol 2001;32:745–749.PubMedGoogle Scholar
  136. 136.
    Beasley MB, Franks TJ, Galvin JR, et al. Acute fibrinous and organizing pneumonia: a histologic pattern of lung injury and possible variant of diffuse alveolar damage. Arch Pathol Lab Med 2002;126:1064–1070.PubMedGoogle Scholar
  137. 137.
    Wall CP, Gaensler EA, Carrington CB, Hayes JA. Comparison of transbronchial and open biopsies in chronic infiltrative lung disease. Am Rev Respir Dis 1981;123:280–290.PubMedGoogle Scholar
  138. 138.
    Housini I, Tomashefski JF, Cohen A, et al. Transbronchial biopsy in patients with pulmonary eosinophilic granuloma: comparison with findings on open lung biopsy. Arch Pathol Lab Med 1994;118:523–530.PubMedGoogle Scholar
  139. 139.
    Flint A, Lloyd RV, Colby TV, Wilson BW. Pulmonary histiocytosis X: immunoperoxidase staining for HLA-DR antigen and S100 protein. Arch Pathol Lab Med 1986;110:930–933.PubMedGoogle Scholar
  140. 140.
    Ree HJ, Kadin ME. Peanut agglutinin: a useful marker for histiocytosis X and interdigitating reticulum cells. Cancer (Philadelphia) 1986;57:282–287.PubMedGoogle Scholar
  141. 141.
    Rabkin MS, Kjeldsberg CR. Epithelial membrane antigen staining patterns of histiocytic lesions. Arch Pathol Lab Med 1987;111:337–338.PubMedGoogle Scholar
  142. 142.
    Azumi N, Sheibani K, Swartz WG, Stroup RM, Rappaport H. Antigenic phenotype of Langerhans cell histiocytosis: an immunohistochemical study demonstrating the value of LN-2, LN-3, and vimentin. Hum Pathol 1988;19:1376–1382.PubMedGoogle Scholar
  143. 143.
    Cagle PT, Mattioli CA, Truong LD, Greenberg SD. Immunohistochemical diagnosis of pulmonary eosinophilic granuloma on lung biopsy. Chest 1988;94:1133–1137.PubMedGoogle Scholar
  144. 144.
    Santamaria M, Llamas L, Ree HJ, et al. Expression of silylated Leu-MI antigen in histiocytosis X. Am J Clin Pathol 1988;89:211–216.PubMedGoogle Scholar
  145. 145.
    Ruco LP, Pulford KAF, Mason DY, et al. Expression of macrophage-associated antigens in tissues involved by Langerhans’ cell histiocytosis (histiocytosis X) Am J Clin Pathol 1989;92:273–279.PubMedGoogle Scholar
  146. 146.
    Rabkin MS, Kjeldsberg CR, Wittwer CT, Marty J. A comparison study of two methods of peanut agglutinin staining with S100 immunostaining in 29 cases of histiocytosis X (Langerhans’ cell histiocytosis) Arch Pathol Lab Med 1990;114:511–515.PubMedGoogle Scholar
  147. 147.
    Fe Y, Huang S, Dong H. Histiocytosis X: S-100 protein, peanut agglutinin, and transmission electron microscopic study. Am J Clin Pathol 1990;94:627–631.Google Scholar
  148. 148.
    Ornvold K, Ralfkiaer E, Carstensen H. Immunohistochemical study of the abnormal cells in Langerhans cell histiocytosis (histiocytosis X). Virchows Arch A Pathol Anat Histopathol 1990;416:403–410.PubMedGoogle Scholar
  149. 149.
    Kanitakis J, Fantini F, Pincelli C, Hermier C, Schmitt D, Thivolet J. Neuron-specific enolase is a marker of cutaneous Langerhans’ cell histiocytosis (“X”): a comparative study with S100 protein. Anticancer Res 1991;11:635–640.PubMedGoogle Scholar
  150. 150.
    Smetana K Jr., Mericka O, Saeland S, et al. Diagnostic relevance of Langerin detection in cells from bronchoalveo-lar lavage of patients with pulmonary Langerhans cell histiocytosis, sarcoidosis and idiopathic pulmonary fibrosis. Virchows Arch 2004;444:171–174.PubMedGoogle Scholar
  151. 151.
    Baumal R, Kahn HJ, Marks A. Role of antibody to S100 protein in diagnostic pathology. Lab Invest 1988;59:152–153 (letter).PubMedGoogle Scholar
  152. 152.
    Webber D, Tron V, Askin F, Churg A. S-100 staining in the diagnosis of eosinophilic granuloma of lung. Am J Clin Pathol 1985;84:447–453.PubMedGoogle Scholar
  153. 153.
    Soler P, Chollet S, Jacque C, Fukuda Y, Ferrans VJ, Basset F. Immunocytochemical characterization of pulmonary histiocytosis X cells in lung biopsies. Am J Pathol 1985;118:439–451.PubMedGoogle Scholar
  154. 154.
    Chollet S, Soler P, Dournovo P, Richard MS, Ferrans VJ, Basset F. Diagnosis of pulmonary histiocytosis X by immunodetection of Langerhans cells in bronchoalveolar lavage fluid. Am J Pathol 1984;115:225–232.PubMedGoogle Scholar
  155. 155.
    Auerswald U, Barth J, Magnussen H. Value of CD-I-positive cells in bronchoalveolar lavage fluid for the diagnosis of pulmonary histiocytosis X. Lung 1991;169:305–309.PubMedGoogle Scholar
  156. 156.
    Emile JF, Wechsler J, Biousse N, et al. Langerhans’ cell histiocytosis: definitive diagnosis with the use of monoclonal antibody O10 on routinely paraffin-embedded samples. Am J Surg Pathol 1995;19:636–641.PubMedGoogle Scholar
  157. 157.
    Bouloc A, Boulland ML, Geissmann F, et al. CD101 expression by Langerhans cell histiocytosis cells. Histopathology 2000;36:229–232.PubMedGoogle Scholar
  158. 158.
    Hammar SP, Winterbauer RH, Bockus D. Diagnosis of eosinophilic granuloma by ultrastructural examination of sputum. Arch Pathol Lab Med 1978;102:606.PubMedGoogle Scholar
  159. 159.
    Powers MA, Askin FB, Cresson DH. Pulmonary eosinophilic granuloma. A 25-year follow-up. Am Rev Respir Dis 1984;129:503–507.PubMedGoogle Scholar
  160. 160.
    Ben-Ezra J, Bailey A, Azumi N, et al. Malignant histiocytosis X: a distinct clinicopathologic entity. Cancer (Philadelphia) 1991;68:1050–1060.PubMedGoogle Scholar
  161. 161.
    Risdall RJ, Dehner LP, Duray P, Kobrinsky N, Robison L, Nesbit ME Jr. Histiocytosis X (Langerhans’ cell histiocytosis): prognostic role of histopathology. Arch Pathol Lab Med 1983;107:59–63.PubMedGoogle Scholar
  162. 162.
    Grogg KL, Lae ML, Kurtin PJ, Macon WR. Clusterin expression distinguishes follicular dendritic cell tumors from other dendritic cell neoplasms: report of a novel follicular dendritic cell marker and clinicopathologic data on 12 additional follicular dendritic cell tumors and 6 additional interdigitating dendritic cell tumors. Am J Surg Pathol 2004;28:988–998.PubMedGoogle Scholar
  163. 163.
    Goldberg N, Bauer K, Rosen ST, et al. Histiocytosis X flow cytometric DNA-content and immunohistochemical and ultrastructural analysis. Arch Dermatol 1986;122:446–450.PubMedGoogle Scholar
  164. 164.
    Rabkin MS, Wittwer CT, Kjeldsberg CR, Piepkorn MW. Flow-cytometric DNA content of histiocytosis X (Langerhans’ cell histiocytosis). Am J Pathol 1988;131:283–289.PubMedGoogle Scholar
  165. 165.
    Ornvold K, Carstensen H, Larsen JK, Christensen J, Ralfkiaer E. Flow cytometric DNA analysis of lesions from 18 children with Langerhans cell histiocytosis (histiocytosis X). Am J Pathol 1990;136:1301–1307.PubMedGoogle Scholar
  166. 166.
    Delobbe A, Durieu J, Duhamel A, et al. Determinants of survival in pulmonary Langerhans’ cell granulomatosis (histiocytosis X). Eur Respir J 1996;9:2002–2006.PubMedGoogle Scholar
  167. 167.
    Vassallo R, Ryu JH, Schroeder DR, et al. Clinical outcomes of pulmonary Langerhans cell histiocytosis in adults. N Engl J Med 2002;346:484–490.PubMedGoogle Scholar
  168. 168.
    Huhn D, Konig G, Weig J, Schneller W. Therapy in pulmonary histiocytosis X. Haematol Bluttransfus 1981;27:231–237.Google Scholar
  169. 169.
    Von Essen S, West W, Sitorius M, Rennard SI. Complete resolution of roentgenographic changes in a patient with pulmonary histiocytosis X. Chest 1990;98:765–767.Google Scholar
  170. 170.
    Chester W. Uber lipoidgranulomatose. Virchows Arch Pathol Anat. 1930;279:561–602.Google Scholar
  171. 171.
    Kenn W, Eck M, Allolio B, et al. Erdheim-Chester disease: evidence for a disease entity different from Langerhans cell histiocytosis? Three cases with detailed radiological and immunohistochemical analysis. Hum Pathol 2000;31:734–739.PubMedGoogle Scholar
  172. 172.
    Bisceglia M, Cammisa M, Suster S, et al. Erdheim-Chester disease: clinical and pathologic spectrum of four cases from the Arkadi M. Rywlin Slide Seminars. Adv Anat Pathol 2003;10(3):160–171.PubMedGoogle Scholar
  173. 173.
    Jaffe HL. Tumors and tumourous conditions of the bone and joints. Philadelphia: Lea & Febiger, 1958:139.Google Scholar
  174. 174.
    Jaffe HL. Metabolic, degenerative, and inflammatory disorders of bone and joints. Philadelphia: Lea & Febiger, 1972:535–541.Google Scholar
  175. 175.
    Chetritt J, Paradis V, Dargere D. Erdheim disease: a neoplastic disorder. Hum Pathol 1999;30:1093–1096.PubMedGoogle Scholar
  176. 176.
    Al-Quran S, Reith J, Bradley J, et al. Erdheim-Chester disease: case report, PCR-based analysis of clonality, and review of literature. Mod Pathol 2002:15:666–672.PubMedGoogle Scholar
  177. 177.
    Veyssier-Belot C, Cacoub P, Caparros-Lefebvre D, et al. Erdheim-Chester disease: clinical and radiologic characteristics of 59 cases. Medicine 1996;75:157–169.PubMedGoogle Scholar
  178. 178.
    Kambouchner M, Colby TV, Donenge C, et al. Erdheim-Chester disease with prominent pulmonary involvement associated with eosinophilic granuloma of mandibular bone. Histopathology 1997;30:353–358.PubMedGoogle Scholar
  179. 179.
    Shamburek RD, Brewer HB, Gochuico BR. Erdheim-Chester disease: a rare multisystem histiocytic disorder associated with interstitial lung disease. Am J Med Sci 2001;321:66–75.PubMedGoogle Scholar
  180. 180.
    Devouassoux G, Lalnteujoul S, Chatelain P, et al. Erdheim-Chester disease: a primary macrophage cell disorder. Am J Respir Crit Care Med 1998;157:650–653.PubMedGoogle Scholar
  181. 181.
    Wittenberg KH, Swensen SJ, Myers JL, et al. Pulmonary involvement with Erdheim-Chester disease: radiographic and CT findings. Am J Roentgenol 2000;174(5):1327–1331.Google Scholar
  182. 182.
    Destombes P. Adenitis and lipid excess, in children or young adults, seen in the Antilles and in Mali (4 cases). Bull Soc Pathol Exot Filiales 1965;58:1035–1039.Google Scholar
  183. 183.
    Rosai J, Dorfman RF. Sinus histiocytosis with massive lymphadenopathy: a newly recognized benign clinicopath-ological entity. Arch Pathol 1969;87:63–70.PubMedGoogle Scholar
  184. 184.
    Menzel C, Hamscho N, Dobert N, et al. PET imaging in Rosai-Dorfman disease: correlation with histopathology and ex-vivo beta-imaging. Arch Dermatol Res 2003;295:280–283.PubMedGoogle Scholar
  185. 185.
    Pulsoni A, Anghel G, Falcucci, P, et al. Treatment of sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): report of a case and literature review. Am J Hematol 2002;69:67–71.PubMedGoogle Scholar
  186. 186.
    Rosai J, Dorfman RF. Sinus histiocytosis with massive lymphadenopathy: a pseudolymphomatous benign disorder. Analysis of 34 cases. Cancer 1972;30:1174–1188.PubMedGoogle Scholar
  187. 187.
    Foucar E, Rosai J, Dorfman RF. Sinus histiocytosis with massive lymphadenopathy. Current status and future directions. Arch Dermatol 1988;124:1211–1214.PubMedGoogle Scholar
  188. 188.
    Thawerani H, Sanchez RL, Rosai J, et al. The cutaneous manifestations of sinus histiocytosis with massive lymphadenopathy. Arch Dermatol 1978;114:191–197.PubMedGoogle Scholar
  189. 189.
    Lussier C, Klijanienko J, Brisse H, et al. Cytology of Rosai-Dorfman disease. Diagn Cytopathol 2001;24:298–300.PubMedGoogle Scholar
  190. 190.
    Sanchez R, Rosai J, Dorfman RF. Sinus histiocytosis with massive lymphadenopathy: an analysis of 113 cases with special emphasis on its extranodal manifestations. Lab Invest 1977;36:21–22.Google Scholar
  191. 191.
    Ng SB, Tan LH, Tan PH. Rosai-Dorfman disease of the breast: a mimic of breast malignancy. Pathology 2000;32:10–15.PubMedGoogle Scholar
  192. 192.
    Wu M, Anderson AE, Kahn LB. A report of intracranial Rosai-Dorfman disease with literature review. Ann Diagn Pathol 2001;5:92–102.Google Scholar
  193. 193.
    Mahar AM, Sporn TA, Roggli VL. Pulmonary extranodal Rosai-Dorfman disease: an unusual mimic of pulmonary carcinoma. Third Biennial Summer Symposium, Pulmonary Pathology Society, Snowmass Village, CO, July 20, 2003.Google Scholar
  194. 194.
    Zander DS, Mergo PJ, Foster RA, et al. Pulmonary parenchymal sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): report of a case with immunohistochemical studies. Mod Pathol 1997;10:174A.Google Scholar
  195. 195.
    Paulli M, Bergamaschi G, Tonon L, et al. Evidence for a polyclonal nature of the cell infiltrate in sinus histiocytosis with massive lymphadenopathy (Rosa-Dorfman disease). Br J Haematol 1995;91:415–418.PubMedGoogle Scholar
  196. 196.
    Ohori NP, Yu Jung, Landreneau RJ, et al. Rosai-Dorfman disease of the pleura: a rare extranodal presentation. Hum Pathol 2003;34:1210–1211.PubMedGoogle Scholar
  197. 197.
    Foucar E, Rosai J, Dorfman R. Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): review of the entity. Semin Diagn Pathol 1990;7:19–73.PubMedGoogle Scholar
  198. 198.
    Long RG, Lake BD, Petetit JE, et al. Adult Niemann-Pick disease: its relationship to the syndrome of the sea-blue histiocyte. Am J Med 1977;62:627–635.PubMedGoogle Scholar
  199. 199.
    Ferretti GR, Lantuejoul S, Branbilla E, et al. Pulmonary involvement in Niemann-Pick disease subtype B: CT findings. J Comput Assist Tomogr 1996;20:990–992.PubMedGoogle Scholar
  200. 200.
    Crocker AC, Farber S. Niemann-Pick disease: a review of eighteen patients. Medicine (Baltimore) 1958;37:1–95.PubMedGoogle Scholar
  201. 201.
    Minai OA, Sullivan EJ, Stoller JK. Pulmonary involvement in Niemann-Pick disease: case report and literature review. Respir Med 2000;94:1241–1251.PubMedGoogle Scholar
  202. 202.
    Gonzalez-Reimers E, Sanchez-Perez MJ, Bonilla-Arjona A, et al. Pulmonary involvement in an adult male affected by Type B Niemann-Pick disease. Br J Radiol 2003;76:838–840.PubMedGoogle Scholar
  203. 203.
    Kolodny EH. Niemann-Pick disease. Curr Opin Haemtol 2000;7:48–52.Google Scholar
  204. 204.
    Ioannou YA. Multidrug permeases and subcellular cholesterol transport. Nat Rev Mol Cell Biol 2001;2:557–668.Google Scholar
  205. 205.
    Jan MM, Camfield PR. Nova Scotia Niemann-Pick disease (type D): clinical study of 20 cases. J Child Neurol 1998;13:75–78.PubMedGoogle Scholar
  206. 206.
    Lachman R, Crocker C, Schluman J, Strand R. Radiological findings in Niemann-Pick disease. Radiology 1973;108:659–664.PubMedGoogle Scholar
  207. 207.
    Lever AML, Ryder JB. Cor pulmonale in an adult secondary to Niemann-Pick disease. Thorax 1983;38:873–874.PubMedGoogle Scholar
  208. 208.
    Skikne MI, Prinsloo I, Webster I. Electron microscopy of lung in Niemann-Pick disease. J Pathol 1972;106:119–122.PubMedGoogle Scholar
  209. 209.
    Niggemann B, Rebien W, Rahn W, et al. Asymptomatic pulmonary involvement in 2 children with Niemann-Pick disease type B. Respiration 1994;61:55–57.PubMedGoogle Scholar
  210. 210.
    Nicholson AC, Wells AU, Hooper J, et al. Successful treatment of endogenous lipoid pneumonia due to Niemann-Pick Type B disease with whole-lung lavage. Am J Respir Crit Care Med 2002;165;128–131.PubMedGoogle Scholar
  211. 211.
    Vellodi A, Hobbs JR, O’Donnell NM, et al. Treatment of Niemann-Pick disease Type B by allogeneic bone marrow transplantation. Br Med J (Clin Res Ed) 1987;295:1375–1376.Google Scholar
  212. 212.
    Elleder M, Chlumska A, Ledvinova J, et al. Testis-A novel storage site in human cholesteryl ester storage disease. Virchows Arch 2000;436:82–87.PubMedGoogle Scholar
  213. 213.
    Fredrickson DS. Newly recognized disorders of cholesterol metabolism. Ann Intern Med 1963;58:718A.Google Scholar
  214. 214.
    Wolman M, Sterk VV, Gatt S, et al. Primary familial xanthomatosis with involvement and calcification of the adrenals: report of two more cases in siblings of a previously described infant. Pediatrics 1961;28:742–757.PubMedGoogle Scholar
  215. 215.
    Elleder M, Chlumska A, Hyanek J, et al. Subclinical course of cholesteryl ester storage disease in an adult with hypercholesterolemia, accelerated atherosclerosis, and liver cancer. J Hepatol 2000;32:528–534.PubMedGoogle Scholar
  216. 216.
    Cagle PT, Ferry GD, Beaudet AL, et al. Clinicopathologic conference: pulmonary hypertension in an 18-year old girl with cholesteryl ester storage disease (CESD). Am J Med Genet 1986;24:711–722.PubMedGoogle Scholar
  217. 217.
    Assman G, Fredrickson, DS. Acid lipase deficiency: Wolman’s disease and cholesteryl ester storage disease. In: Stanbury JB, Wyngaarden JB, Fredrickson DS, Goldstein JL, Brown MS, eds. The metabolic basis of inherited disease. 5th ed. New York: McGraw-Hill, 1983:803–819.Google Scholar
  218. 218.
    Laga AC, Allen T, Dishop M, et al. Storage diseases. In: Cagle PT, ed. Color atlas and text of pulmonary pathology. Philadelphia: Lippincott Williams & Wilkins, 2005:575–576.Google Scholar
  219. 219.
    Michels VV, Driscoll DJ, Ferry GD, et al. Pulmonary vascular obstruction associated with cholesteryl ester storage disease. J Pediatr 1979;94:621–623.PubMedGoogle Scholar
  220. 220.
    Lee RE, Yousem SA. The frequency and type of lung involvement in patients with Gaucher’s disease. Lab Invest 1988;58:54A.Google Scholar
  221. 221.
    Amir G, Ron N. Pulmonary pathology in Gaucher’s disease. Hum Pathol 1999;30:666–670.PubMedGoogle Scholar
  222. 222.
    Zimran A, Kay A, Gelbart T, et al. Gaucher disease: clinical, laboratory, radiologic and genetic features of 53 patients. Medicine 1992;71:337–353.PubMedGoogle Scholar
  223. 223.
    Goitein O, Elstein D, Abrahamov A, et al. Lung involvement and enzyme replacement therapy in Gaucher’s disease. Q J Med 2001;94:407–415.Google Scholar
  224. 224.
    Ross D, Spira S, Buchbinder NA. Gaucher cells in pulmonary capillary blood in association with pulmonary hypertension. N Engl J Med 1997;336:379–381.PubMedGoogle Scholar
  225. 225.
    Kelly MM, Leigh R, McKenzie R, et al. Induced sputum examination: diagnosis of pulmonary involvement in Fabry’s disease. Thorax 2000;55:720–721.PubMedGoogle Scholar
  226. 226.
    Brown LR, Miller A, Bhuptani A, et al. Pulmonary involvement with Fabry disease. Am J Respir Crit Care Med 1997;155:1004–1010.PubMedGoogle Scholar
  227. 227.
    Bagdade JD, Parker F, Ways PO, et al. Fabry’s disease: a correlative clinical, morphologic and biochemical study. Lab Invest 1968;18:681–688.PubMedGoogle Scholar
  228. 228.
    Rosenberg DM, Ferrans VJ, Fulmer JD, et al. Chronic airflow obstruction in Fabry’s disease. Am J Med 1980;68:898–905.PubMedGoogle Scholar
  229. 229.
    Smith P, Heath D, Rodgers B, et al. Pulmonary vasculature in Fabry’s disease. Histopathology 1991;19:567–569.PubMedGoogle Scholar
  230. 230.
    Ferrans VJ, Hibbs RG, Burda CD. The heart in Fabry’s disease: a histochemical and electron microscopic study. Am J Cardiol 1969;24:95–110.PubMedGoogle Scholar
  231. 231.
    Huizing M, Anikster Y, Gahl WA. Hermansky-Pudlak syndrome and Chediak-Higashi syndrome: disorders of vesicle formation and trafficking. Thromb Haemost 2001;86:233–245.PubMedGoogle Scholar
  232. 232.
    Brantly M, Villia NA, Shotelersuk, V, et al. Pulmonary function and high resolution CT findings in patients with an inherited form of pulmonary fibrosis, Hermansky-Pudlak syndrome, due to mutations in HPS-1. Chest 2000;117:129–136.PubMedGoogle Scholar
  233. 233.
    Schinella RA, Greco MA, Cobert BL, et al. Hermansky-Pudlak syndrome with granulomatous colitis. Ann Intern Med 1980;92:20–23.PubMedGoogle Scholar
  234. 234.
    Witkop CJ, Krumwiede M, Sedano H, et al. Reliability of absent platelet dense bodies as a diagnostic criterion for Hermansky-Pudlak syndrome. Am J Hematol 1987;26:305–311.PubMedGoogle Scholar
  235. 235.
    Reynolds SP, Davies BH, Gibbs AR. Diffuse Pulmonary Fibrosis and the Hermansky-Pudlak syndrome: clinical course and post-mortem findings. Thorax 1994;409:617–618.Google Scholar
  236. 236.
    Harmon KR, Witkop CJ, White JG, et al. Pathogenesis of pulmonary fibrosis: platelet-derived growth factor precedes structural alterations in the Hermansky-Pudlak syndrome. J Lab Clin Med 1994;123:617–627.PubMedGoogle Scholar
  237. 237.
    Gahl WA, Brantly MI, Kaiser-Kupfer F, et al. Genetic defects and clinical characteristics of patients with a form of occulocutaneous albinism (Hermansky-Pudlak syndrome). N Engl J Med 1998;338:1258–1264.PubMedGoogle Scholar
  238. 238.
    Nakatani Y, Nakamura N, Sano J, et al. Interstitial Pneumonia in Hermansky-Pudlak Syndrome: marked significance of florid foamy swelling/degeneration (giant lamellar body degeneration) Type II Pneumocytes. Virchows Arch (A) 2000;437:304–313.Google Scholar
  239. 239.
    Reineila A. Perivascular xanthogranulomatosis in the lungs of diabetic patients. Arch Pathol Lab Med 1976;100:542–543.Google Scholar
  240. 240.
    Lightman NI, Schooley RT. Adult on-set acid maltase deficiency: case report of an adult with severe respiratory difficulty. Chest 1977;72:250–252.PubMedGoogle Scholar
  241. 241.
    Spencer H. Pathology of the lung excluding pulmonary tuberculosis. 3d ed. Oxford: Pergamon, 1977.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Samuel P. Hammar
    • 1
  • Timothy C. Allen
    • 2
  1. 1.Harrison Medical CenterPathology Associates of Kitsap CountyBremertonUSA
  2. 2.Department of PathologyUniversity of Texas Health Center at TylerTylerUSA

Personalised recommendations